|
FSIS Guideline - Program for Certifying Pork Intended for Export to the European Union (PFEU Program)
The Food Safety and Inspection Service (FSIS) is responsible for certifying that meat exported from the United
States (US) to the European Union (EU) originates from animals that have never been treated with hormonal
growth promotants1.
Member states shall prohibit the importation of meat or products obtained from animals from third countries...
to which products or substances having a thyrostatic, oestrogenic, androgenic or gestagenic action and/or
beta-agonists have been administered to animals by any means whatsoever (Article 11.)
Reference: Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain
substances having a hormonal or thyrostatic action and of beta-agonists, and repealing Directives
81/602/EEC, 88/146/EEC and 88/299/EEC.
Member states are authorized to import animals and animal products provided the third country submits a plan
setting out the guarantees which it offers as regards the monitoring of the groups of residues and substances
referred to in Annex I (Article 29)
Reference: Council Directive 96/23/EC on measures to monitor certain substances and residues thereof in live animals
and animal products and repealing Directives 85/358/EEC and 86/469/EEC and Decisions 89/187/EEC and 91/664/EEC.
System Requirements
In order for FSIS, as the competent authority, to provide export certification for product
produced without hormonal growth promotants, there must be assurances that there are effective
controls in all applicable phases of production in growing the animal, as well as at the slaughter
establishment. Though each phase or ownership stage will have to demonstrate that their system
controls are adequate and are meeting the standard, emphasis will be placed on the finishing
unit, which is where the compound is approved for use. An independent, third party must certify
to compliance with the conditions outlined herein. The laboratory results from analyses of tissue
samples collected at slaughter will help to verify the effectiveness of these controls.
Pork Production for the European Union
In December 1999, the U.S. Food and Drug Administration (FDA), Center for Veterinary Medicine
(CVM) approved the ß -agonist, ractopamine hydrochloride (hereafter
referred to as ractopamine) as a swine feed ingredient2. This compound (Type A
medicated article) is sold as a pre-mix without veterinary prescription over the counter
(labeled as Paylean™), directly to feed mills and producers, to be incorporated in
rations intended to be fed the last 90 pounds of the finishing period or roughly the final
six weeks prior to slaughter. As a result of this approval and subsequent use by the swine
industry, any pork intended for export to the European Union must be produced under a documented
control system that will provide assurances that ractopamine has not been fed to the animal.
Production controls in feed mills
Animal feed manufacturers must provide feed produced-whether medicated or non-medicated-which
meets the intended specifications and is not adulterated. The FDA established the Current Good
Manufacturing Practice (CGMP) Regulations for Medicated Feeds, which require medicated feed
manufacturers to assure that their products meet these specifications. All manufacturers of
medicated feed, including commercial manufacturers as well as on-farm mixing operations are
subject to these requirements. The Federal Food, Drug, and Cosmetic Act provides that a medicated
feed containing an animal drug is considered adulterated if not produced in conformance with
CGMPs. Appropriate regulatory action is taken in the event that feeds are adulterated or
mislabeled.
Animal feed manufacturers participating in the production of rations free of ractopamine will
provide the pork production system with a letter of guarantee assuring that the feed has been
prepared following standard operating procedures that assure the feed does not contain
ractopamine (using the CGMP regulations specified in 21 CFR Part 225 as guidance). In addition,
assurances will be made that all persons involved with the production of feed for this program
are knowledgeable of the requirements of the program and have been adequately trained. The feed
manufacturer shall keep appropriate records to demonstrate that the feed meets the required
specifications. These records must be made available to both internal and external auditors
upon request. Periodic assays are required to demonstrate that the feed meets the appropriate
specifications. The feed manufacturer issuing the letter of guarantee will perform these assays.
In addition, the pork production system will conduct internal audits of the feed manufacturer
to assure compliance with the guarantees stated.
Production controls prior to finishing
Conditions of use for ractopamine restrict feeding a complete ration containing at least 16
percent protein to finishing swine from 150 to 240 pounds body weight (21 CFR 558.500). This
product is not permitted for use in breeding swine. Suppliers that provide hogs to finishing
operations that are participating in this program must provide written assurances, in the format
of a producer affidavit3, that ractopamine has not been fed during this production
phase. Appropriate documentation and records must be maintained by the operation to validate
this claim. These records must be made available to both internal and external auditors upon
request. The pork production system will conduct internal audits of the operations supplying
hogs to assure compliance with the guarantees stated.
Production controls in finishing operations
The pork production system finishing hogs for the production of meat intended for export to the
EU must maintain a written program that describes procedures for maintaining identity of and
segregating hogs, as well as the controls necessary to prevent the administration of restricted
compounds to each group of animals. The program must describe frequencies for monitoring and
verifying that effective controls are in place. Corrective actions, with preventative measures
in response to any deviations, should be included in the program. In addition, the plan must
include record keeping activities. Appropriate records for each lot of animals presented to the
EU-approved slaughter establishment must be maintained by the operator to validate every step in
the process. These records must be made available to both internal and external auditors upon
request.
Any pork production system interested in producing animals for slaughter and subsequent shipment
to the EU must have their control programs approved prior to feeding hogs under this program. The
control program must comply with the program requirements for traceability and identification.
Emphasis will be placed on the ability to demonstrate and document sufficient identification of
animals that have never been fed ractopamine. Producer affidavits are a component of the program
supplied by the farrowing unit, nursery unit, growing unit, and/or finishing unit, as applicable,
which will provide assurances that each lot of hogs presented for slaughter has not been fed
ractopamine.
The documented program will be reviewed, audited, and approved by the USDA, Agricultural
Marketing Service (AMS), Livestock and Seed Programs (LSP) or by an independent third party that
has been accredited by AMS, to assure compliance with these conditions. These conditions are
outlined in the "Components of the Program" provided with this document. Independent third party
audit groups must be accredited by AMS in accordance with ISO Guide 654 requirements
relative to providing certification services.
Production controls in slaughter establishments
All hogs must be slaughtered in a federally inspected slaughter establishment approved for export
to the EU. If carcass meat is boned or stored in the United States, this process must be carried
out in an EU approved cutting plant and/or cold storage facility. Each establishment must have a
written control program and procedures in place that will assure the production and shipment of
product derived from hogs that have not been fed ractopamine. The FSIS Inspector-in-charge (IIC)
will review the establishment's written program to determine if it is adequate to maintain
controls throughout the slaughter, fabrication, processing, packaging process, and subsequent
storage. In addition, FSIS inspection personnel will be responsible for continuous monitoring of
the program by performing random checks of these procedures and records throughout the EU
production.
In order to assure continuity of product identification and traceability of the entire system's
program, AMS will conduct an initial document review of the EU-approved establishment's written
procedures for the control and segregation program. However, FSIS will maintain oversight in the
establishment.
Analytical Verification Program
In addition to the audited documented system requirements, all slaughter establishments approved
for export of meat and/or offals to the EU are required to participate in the EU Additional
Residue Testing Program, which is administered by FSIS. In accordance with Directive 96/23/EC,
a targeted number of samples are collected and analyzed for the presence of residues. These
monitoring samples are tested at industry expense in independent laboratories participating in
the Agricultural Marketing Service's European Meat Export Laboratory Program. The results, which
are reported to both plant management and FSIS, provide verification of the effectiveness of the
program to prevent use of hormones in meat intended for the EU. FSIS summarizes and reports these
results to the EU annually.
In the event that a confirmed violative positive result is reported by the laboratory, FSIS will
coordinate the appropriate follow-up, including notification to the Food and Drug Administration
(FDA), AMS and FSIS District Enforcement Operations (DEO), depending upon which compound has
been detected. AMS will immediately suspend all approvals for applicants in the product chain of
custody pending a complete investigation. Suspension will remain in effect until objective
evidence is provided that the system has been completely purged of all affected products and
an on-site audit verifies that effective corrective action has been taken. FDA and FSIS/DEO will
pursue regulatory action including criminal prosecution, where warranted. Each phase or ownership
stage will independently have to demonstrate that their system requirements are adequate and are
meeting the standard prior to reinstatement of the program, in accordance with AMS guidelines
(MGC Instruction 710).
Components of the Program
- Feed Manufacturers
- Components
- Adequate procedures will be established and maintained for
identification, storage and inventory control of feeds not containing ractopamine (note: if no ractopamine is introduced into the system, identification, storage and inventory control of feeds will not be required);
- Establish and maintain Standard Operating Procedures specific to
preventing the contamination of feeds with ractopamine. Include specifications for sequencing, flushing and equipment clean out procedures.
- A letter of guarantee that the feed does not contain ractopamine will be provided to the pork production system receiving the feed produced under this program.
- Laboratory Assays
Feeds produced under this program will be assayed periodically (at minimum, 2 times per year) to demonstrate that ractopamine is not present.
- Labeling
All feed must be properly labeled and handled in a manner that prevents mix-ups.
- Record Keeping
Appropriate records must be maintained for all phases
of production and distribution to support the controls and enable traceback
to a specific batch if necessary.
- Finishing Operations (verified by third party)
- Written Program Manual
The pork production system finishing hogs for the production of meat intended for export to the EU shall prepare and maintain a program manual that contains, at minimum:
- a description of the legal status of the supplier;
- the names and positions of persons with responsibilities for operation
under the program;
- the names of all persons authorized to sign affidavits attesting to the
non-hormone treatment of animals;
- maps and/or legal descriptions of specific locations where hogs are
maintained;
- all operating policies and procedures or work instructions addressing
controls specific to the site where the hogs are maintained (must be clear and
sequential);
- a list of all feeds and supplements and their sources;
- completed examples of all forms, tags and labels used in operation and
management of the program.
- This program manual must be signed and dated by a responsible
representative of the company.
- On-farm Animal Identification
Each group of animals, as defined by the pork production system,
must be identified with a unique identification to maintain segregation and to facilitate traceback throughout
the system, in the event of a violation. The identification system must include:
- records of the names and addresses of the places where animals for
finishing originated, if different from the site where hogs are maintained for
finishing;
- specifications for purchasing weaned or feeder hogs
- letter of assurance (producer affidavit) that these hogs meets these
specifications
- first hand knowledge that these requirements have been met
- type of system used to identify groups of animals (such as ear clips, ear
tags, tattoos, ear notches) and at what point this identification is applied;
- Each lot's identification must be listed in the supplier's records;
- disposition of animals that are excluded or taken out of program;
- procedures for ensuring each lot of hogs is traceable throughout the
system;
- Loss of identification. Written procedures must be maintained for ensuring
animals with lost identification are correctly re-identified or excluded from
the program.
- Process Controls
Every step in the process where controls are needed to assure that only non-ractopamine fed hogs are
presented for slaughter must be described, complete with frequencies for monitoring and means of verification
that the controls are effective. These controls should include:
- Identification of the type of operation (i.e. farrow/finish; wean/finish; grow/finish, etc.)
- Feeds and feeding. Hogs must not have been fed ractopamine at any time during the life of the animal.
- records of all rations used to feed hogs to demonstrate program
compliance, including the source of the feed and whether any supplements or
additives are used;
- maintain letter of guarantee for all sources of pre-mixed feeds;
- conduct regular, detailed reviews of sources that process feeds containing ractopamine;
- select weekly random samples of feed deliveries into the production
system;
- feeds mixed on farm under this program will be assayed periodically (at
minimum, 2 times per year) to demonstrate that ractopamine is not present.
- Control and segregation.
- procedures to ensure program animals are not commingled with animals fed ractopamine;
- procedures to ensure feed treated with ractopmamine does not cross contaminate with c. program feed that does not contain ractopamine;
- identification of any ractopamine substances on premises.
- Shipping.
- procedures for controlling animals during transport to slaughter establishment with affidavits
- procedures for issuing and controlling the distribution of affidavits
attesting to the non-ractopamine treatment for each shipment
- all sales, movements or transport of hogs will be recorded in the
supplier's records.
- Records to verify procedures and evaluations have been performed.
- Producer Affidavits
Signed statements from each production segment will attest to the non-hormone treatment of animals identified on the affidavit (see annex 2).
- The affidavit must accompany the animals to the slaughter establishment.
The affidavit must include the following information:
- FSIS inspected EU approved slaughter establishment where animals will be slaughtered;
- provide sufficient description to permit identification and traceability
of the lot of animals and total number of animals included in transport;
- statement attesting to full responsibility for the relevant practices
applied to producing hogs that have never been fed ractopamine;
- AMS approval number;
- date of dispatch;
- Warning statement: Persons willfully making false, fictitious, or
fraudulent statements or entries are subject to fine or imprisonment or both
as prescribed by Title 18 U.S. Code 1001.
- Animals owned or under control of other persons or at other premises must
have affidavits on file from each such owner
- Must be signed by a person authorized and listed in the approved program
manual
- Affidavits must be maintained on file with other documents.
- Educational Program
All employees involved in the program must be knowledgeable of the requirements,
including but not limited to animal identification procedures, segregation procedures, and ineligible
compounds. The educational programs should include:
- procedures for ensuring all persons with program responsibilities are
properly trained in relevant aspects of the program;
- records supporting that suppliers are knowledgeable of the requirements of
the program
- records of persons trained and the scope of the training received.
- Record Keeping
Appropriate records must be maintained for all phases of
the operation to provide traceability and control of identity of the origin of the
animals in addition to supporting the system of controlling banned substances.
- Records must be maintained in a manner so as to prevent loss, damage, or
alteration and be easily accessible.
- Records should be maintained for a period projected to be one year after
the export of the meat that is produced from such animals.
- Records must be made available for inspection by AMS or other third party auditors.
- Internal Audits
An internal assessment of the performance of the operation will be conducted periodically
(at minimum 2 times per year) at every phase of the process. This assessment will be documented.
- In-plant Slaughter and Processing Controls
- Program Requirements
- Written notification must be provided to the FSIS IIC prior to EU production;
- System must ensure products received, processed, or shipped are identified
and are traceable to AMS approved production system or supplier;
- Animals received or shipped must be accompanied by a signed affidavit
attesting to the to full responsibility for the relevant practices applied to
producing hogs that have never been fed ractopamine;
- All persons with responsibilities for program activities must have a
complete understanding of program requirements relevant to their area of
responsibility.
- Written Program ManualAll operating procedures related to the control of and segregation of
non-hormone treated animals through slaughter, cutting and packaging must be documented. These
procedures must include:
- a description of the legal status of the establishment;
- the names and positions of persons in managerial responsibilities for
operation of the certified program;
- the names of all persons authorized to sign affidavits that the products
originated from production systems not feeding ractopamine;
- diagrams and/or descriptions of locations where products are stored or
processed;
- clear, sequential, operating policies and procedures or work instructions,
specific to the establishment seeking approval, that address the entire
process, from receiving animals for slaughter, transfer of carcasses into
cooler, transfer of carcasses into the cutting room or to another cutting
plant, transfer of cuts into the shipping carton and subsequent storage.
- Completed examples of all forms, tags, and labels used by the supplier to
track products or demonstrate program compliance;
- This program manual must be signed and dated by a responsible
representative of the company.
- Identification
Documented procedures for identification, segregation and proper handling of product throughout
the entire process to maintain segregation and to facilitate traceback throughout the system.
The identification system must include:
- Sufficient identification of each carcass component or container to
provide cross referenced documentation from the identification of the animals
at receiving (and the affidavit) to the identification system in-plant;
- Record of the signed affidavit accompanying the lot of animals;
- Method of identification clearly distinguishing EU product from non-EU product;
- Loss of identification. Written procedures must be maintained for ensuring
animals or product with lost identification are correctly re-identified or
excluded from the program.
- Production Controls
Every step in the process where controls are needed to assure that only non-hormone treated animals
are slaughtered must be described, complete with frequencies for monitoring and means of verification
that the controls are effective. These controls should include:
- Segregation of non-hormone treated animals (carcasses/meat) from
non-program animals (carcasses/meat)
- Procedures that account for the disposition of animals and products
excluded from the program
- Records related to the number of animals presented for slaughter and the
number of animals slaughtered for the EU
- Storage and inventory control of the EU oval health mark (including labels and brands)
- Records supporting control of product transferred to separate cutting
facilities and cold storage warehouses
- Educational Program
All employees involved in the production of non-hormone treated meat must be knowledgeable of the
requirements of this program, including but not limited to animal/meat product identification
procedures, segregation procedures, and laboratory sampling procedures. The educational programs
should include:
- Access to documented company procedures as well as access to the current
version of the EU Export Requirements located in the FSIS Export Library
- Record of communication of any changes to the program;
- Procedures for ensuring all persons with program responsibilities are
properly trained in relevant aspects of the program;
- Records supporting that suppliers are knowledgeable of the requirements of
the program;
- Records of persons trained and the scope of the training received
- Transfer Affidavits
Signed statements from each production segment will attest to the non-hormone treatment of animals
identified on the affidavit (see annex 3). A copy of the affidavit accompanying the animals to
the slaughter establishment will remain on file with other documents. The transfer affidavit will
have sufficient description to permit identification and traceability of the meat products
through the system back to the origin of the animals.
- Internal Audits
An internal assessment of the performance of the operation will be conducted periodically (at minimum two times
per year) at every phase of the process. This assessment will be documented.
- Record Keeping
Appropriate records must be maintained for all phases of the operation to provide traceability and control of
identity of the origin of the animals.
- Records must be maintained in a manner so as to prevent loss, damage, or
alteration and be easily accessible
- Records must be maintained for a period of at least one year after the
export of the meat that is produced from such animals.
- Records must be made available for inspection by FSIS or other third party auditor.
Annex 1
These substances have thyrostatic, oestrogenic, androgenic or gestagenic action. They are used to increase feed efficiency,
accelerate attainment of market weight and improve carcass quality. The compounds include drugs
such as methylthiouracil, zeranol (Ralgro), melengestrol acetate (MGA), endogenous sex steroids
(Synovex-S, Synovex-H, Compudose 200 and 400), trenbolone acetate (Revalor-S, H or G,
Finapix-H, S) and ractopamine hydrochloride (Paylean).
GROUP A of Annex I - Substances having anabolic effect and unauthorized substances
- Stilbenes, stilbene derivatives, and their salts and esters
- Diethylstilbestrol (DES)
- Hexoestrol
- Dienoestrol
- Anti-thyroid agents
- Thyreostats (2 - thirouracil)
- Steroids
- Melengestrol acetate (MGA)
- 19 Nortestosterone (17-? and 17-?)
- Trenbolone acetate (17-?, 17-?)
- Resorcylic acid lactones including zeranol
- Beta-agonists
- Clenbuterol
- Salbutamol
- Cimaterol
- Ractopamine hydrochloride
- Compounds included in Annex IV to Council Regulation (EEC) No. 2377/90 of
June 26, 1990
- Nitrofurans
- Chloramphenicol
- Dimetridazole (hydroxy metabolite)
Note: The targeted number of samples for each compound included in the EU Additional Residue
Testing Program can be found in the FSIS Export Requirement Library (www.fsis.usda.gov)
1Prohibited compounds are listed in Annex 1
2 21 CFR Part 556-Tolerances for residues of new animal drugs in food
(§556.570 Ractopamine) and Part 558-New animal drugs for use in animal feeds (§ 558.500
Ractopamine).
3 Terminology for producer affidavits is included in the sample
affidavit presented in Annex 2.
4 ISO (International Organization for Standardization), IEC
(International Electrotechnical Commission) Guide 65: General requirements for bodies operating
product certification systems. Copies can be obtained from American National Standards Institute,
11 West 42nd Street, New York, New York 10036. Tel (212) 642-4900, facsimile
(212) 398-0023. Website: www.ansi.org.
|
|
|
|